Literature DB >> 27130358

Piperidinyl thiazole isoxazolines: A new series of highly potent, slowly reversible FAAH inhibitors with analgesic properties.

Stephen O Pember1, Galo L Mejia2, Theodore J Price3, Robert J Pasteris4.   

Abstract

Fatty acid amide hydrolase (FAAH) is a membrane anchored serine hydrolase that has a principle role in the metabolism of the endogenous cannabinoid anandamide. Docking studies using representative FAAH crystal structures revealed that compounds containing a novel piperidinyl thiazole isoxazoline core fit within the ligand binding domains. New potential FAAH inhibitors were designed and synthesized incorporating urea, carbamate, alkyldione and thiourea reactive centers as potential pharmacophores. A small library of candidate compounds (75) was then screened against human FAAH leading to the identification of new carbamate and urea based inhibitors (Ki=pM and nM, respectively). Representative carbamate and urea based chemotypes displayed slow, time dependent inhibition kinetics leading to enzyme inactivation which was slowly reversible. However, evidence indicated that features of the mechanism of inactivation differ between the two pharmacophore types. Selected compounds were also evaluated for analgesic activity in the mouse-tail flick test.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Analgesia; Fatty acid amide hydrolase; Inactivation; Inhibition; Piperidinyl thiazole isoxazoline

Mesh:

Substances:

Year:  2016        PMID: 27130358      PMCID: PMC4936272          DOI: 10.1016/j.bmcl.2016.02.061

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  27 in total

1.  An efficient randomised, placebo-controlled clinical trial with the irreversible fatty acid amide hydrolase-1 inhibitor PF-04457845, which modulates endocannabinoids but fails to induce effective analgesia in patients with pain due to osteoarthritis of the knee.

Authors:  John P Huggins; Trevor S Smart; Stephen Langman; Louise Taylor; Tim Young
Journal:  Pain       Date:  2012-06-21       Impact factor: 6.961

Review 2.  The endocannabinoid system: drug targets, lead compounds, and potential therapeutic applications.

Authors:  Didier M Lambert; Christopher J Fowler
Journal:  J Med Chem       Date:  2005-08-11       Impact factor: 7.446

3.  A MBP-FAAH fusion protein as a tool to produce human and rat fatty acid amide hydrolase: expression and pharmacological comparison.

Authors:  G Labar; F V Vliet; J Wouters; D M Lambert
Journal:  Amino Acids       Date:  2007-05-04       Impact factor: 3.520

Review 4.  Discovery and development of fatty acid amide hydrolase (FAAH) inhibitors.

Authors:  Mark Seierstad; J Guy Breitenbucher
Journal:  J Med Chem       Date:  2008-12-11       Impact factor: 7.446

5.  Crystal structure of fatty acid amide hydrolase bound to the carbamate inhibitor URB597: discovery of a deacylating water molecule and insight into enzyme inactivation.

Authors:  Mauro Mileni; Satwik Kamtekar; David C Wood; Timothy E Benson; Benjamin F Cravatt; Raymond C Stevens
Journal:  J Mol Biol       Date:  2010-05-21       Impact factor: 5.469

6.  A high throughput fluorescent assay for measuring the activity of fatty acid amide hydrolase.

Authors:  Karen L Kage; Paul L Richardson; Linda Traphagen; Jean Severin; Ana Pereda-Lopez; Thomas Lubben; Rachel Davis-Taber; Melissa H Vos; Diane Bartley; Karl Walter; John Harlan; Larry Solomon; Usha Warrior; Thomas F Holzman; Connie Faltynek; Carol S Surowy; Victoria E Scott
Journal:  J Neurosci Methods       Date:  2006-11-02       Impact factor: 2.390

7.  Cyclohexylcarbamic acid 3'- or 4'-substituted biphenyl-3-yl esters as fatty acid amide hydrolase inhibitors: synthesis, quantitative structure-activity relationships, and molecular modeling studies.

Authors:  Marco Mor; Silvia Rivara; Alessio Lodola; Pier Vincenzo Plazzi; Giorgio Tarzia; Andrea Duranti; Andrea Tontini; Giovanni Piersanti; Satish Kathuria; Daniele Piomelli
Journal:  J Med Chem       Date:  2004-10-07       Impact factor: 7.446

8.  AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility.

Authors:  Garrett M Morris; Ruth Huey; William Lindstrom; Michel F Sanner; Richard K Belew; David S Goodsell; Arthur J Olson
Journal:  J Comput Chem       Date:  2009-12       Impact factor: 3.376

9.  Optimization of the central heterocycle of alpha-ketoheterocycle inhibitors of fatty acid amide hydrolase.

Authors:  Joie Garfunkle; Cyrine Ezzili; Thomas J Rayl; Dustin G Hochstatter; Inkyu Hwang; Dale L Boger
Journal:  J Med Chem       Date:  2008-07-16       Impact factor: 7.446

Review 10.  Chemical probes of endocannabinoid metabolism.

Authors:  Jacqueline L Blankman; Benjamin F Cravatt
Journal:  Pharmacol Rev       Date:  2013-03-19       Impact factor: 25.468

View more
  5 in total

1.  (Indolylalkyl)piperidine carbamates as inhibitors of fatty acid amide hydrolase (FAAH).

Authors:  Helmut Dahlhaus; Walburga Hanekamp; Matthias Lehr
Journal:  Medchemcomm       Date:  2017-01-30       Impact factor: 3.597

2.  Role of N-Arachidonoyl-Serotonin (AA-5-HT) in Sleep-Wake Cycle Architecture, Sleep Homeostasis, and Neurotransmitters Regulation.

Authors:  Eric Murillo-Rodríguez; Vincenzo Di Marzo; Sergio Machado; Nuno B Rocha; André B Veras; Geraldo A M Neto; Henning Budde; Oscar Arias-Carrión; Gloria Arankowsky-Sandoval
Journal:  Front Mol Neurosci       Date:  2017-05-30       Impact factor: 5.639

3.  New Series of Thiazole Derivatives: Synthesis, Structural Elucidation, Antimicrobial Activity, Molecular Modeling and MOE Docking.

Authors:  Ismail Althagafi; Nashwa El-Metwaly; Thoraya A Farghaly
Journal:  Molecules       Date:  2019-05-04       Impact factor: 4.411

4.  Design, synthesis and docking studies of novel thiazole derivatives incorporating pyridine moiety and assessment as antimicrobial agents.

Authors:  Rizk E Khidre; Ibrahim Ali M Radini
Journal:  Sci Rep       Date:  2021-04-12       Impact factor: 4.379

5.  Synthesis, DFT Analysis, and Evaluation of Antibacterial and Antioxidant Activities of Sulfathiazole Derivatives Combined with In Silico Molecular Docking and ADMET Predictions.

Authors:  Yoseph Samuel; Ankita Garg; Endale Mulugeta
Journal:  Biochem Res Int       Date:  2021-12-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.